Heart Health & Cardiovascular Technology
February 26 @ 11am – 2pm ET
Share:
Director, Exercise-Oncology Program
11:00 AM
Mike Meaney, PhD, Co-founder and CEO, One Small Step
11:15 AM
Steve Mair, Healthcare Operations Facility Administrator at Fresenius Medical Care
11:25 AM
Ravi Kondadadi, Chief Technical Officer, Pulp Digital AI
11:35 AM
Dr. Jason Lazar, Executive Vice Dean, SUNY Downstate College of Medicine
11:45 AM
Wayne Cafran, Board member, HITLAB Women’s Health Tech Initiative
Dr. Mary Catherine George, Director of Clinical Research Program, Icahn School of Medicine at Mount Sinai
12:00 PM
Divya Verma, Chair, WHTI & Vice President of Business Development @ Accord Healthcare US
Juliana Berman, Pharma Digital Strategy Leader
12:10 PM
Vlastimil Hrabal, CEO & Co-Founder at KARDI AI
Dr. Sonia Gupta, Chief Medical Officer, Enterprise Imaging, Optum
Dr. Meghna Mittal, Director of AI Technology at Elevance Health
Alice Chung, US Medical – Field Medical: Integrated Engagement & Process Enablement Lead, Genentech
Tamer Chowdhury, Data Governance Manager, Boehringer Ingelheim
Sarianne Gruber, Principal, SG Analytics
Nasibeh Zanjirani Farahani, PhD, MS, CSM Assistant Professor of Medicine , Mayo Clinic
Jessica Scott, PhD, Director, Exercise-Oncology Program, Memorial Sloan Kettering Cancer Center
Want to speak, sponsor, or participate more in our events?
Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.
IMC is the global leader in smart medication adherence solutions, having supplied over a million units to the clinical trials and research markets. IMC manufactures iOS and Android NFC-certified Med-ic Smart Blister Packages, eCAP Smart Medication Bottles and the temperature-aware Med-ic Smart Syringe Pack. IMC is active in the AI-enabled digital health field, offering its HIPAA compliant, secure CertiScan clinical research adherence cloud. IMC’s latest Lilipond AI project is aimed at detecting opiate abuse early to avoid dependence and addiction.
FINN Partners is more than an integrated marketing agency. We are smart, passionate communications advocates on a mission to make a difference in the world. We change the way brands relate to their markets. The way companies are positioned and perceived. The way causes become movements. How stakeholders view stakes. How great stories are told and shared to earn attention. Where leads are generated and results tracked. We’ve even changed the way people within an agency collaborate and pull together for the greater good. Our work reflects our values. What we do is how we do things. Whether inside our walls or on the front lines of business transformation and social change, we stand together to create meaningful and measurable impact on the world around us.